API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 134 articles Forum Github 13 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. MYNZ.NASDAQ

Mainz Biomed BV (MYNZ NASDAQ) stock market data APIs

$0.257 0.01(4%) as of September 19, 2024
Price chart is built with Anychart

Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. The company was founded in 2008 and is based in Mainz, Germany.

Mainz Biomed BV Financial Data Overview

0.2499
0.257
-
0.28
0.243
0.2271-3.392
5 561 K
21 887 K
895 K
0.12
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'MYNZ',
Type: 'Common Stock',
Name: 'Mainz Biomed BV',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG012XZKGW7',
ISIN: 'NL0015000LC2',
CUSIP: NULL,
CIK: '1874252',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-11-05',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Diagnostics & Research',
HomeCategory: NULL,
IsDelisted: false,
}

Mainz Biomed BV Fundamental Data is available in our Financial Data APIs

  • Net Revenue 895 K
  • EBITDA -26 074 670
  • Earnings Per Share -1.62
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Mainz Biomed BV Earnings via APIs

  • Latest Release 2024-09-16
  • EPS/Forecast -0.25

Get Mainz Biomed BV End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Mainz Biomed BV latest news via APIs

Pfizer Records First Sales Growth In Its Post-Covid Era And It Owes It To Cancer

Pfizer Records First Sales Growth In Its Post-Covid Era And It Owes It To Cancer The market for vaccines and treatments used in managing COVID-19 has shrunk by billions of dollars a year. Forced to ...

mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment

mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment The medical and pharmaceutical community continues to embrace emerging technologies, beginning with mRNA that ros...
Do you have any questions?
support@eodhistoricaldata.com